The Association of Genetic Polymorphisms Within the Dopaminergic System with Nicotine Dependence: A Narrative Review

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Jul 18

PMID 39021905

Authors

Jingjing Yang

Hongjuan Wang

Huan Chen

Hongwei Hou

Qingyuan Hu

Affiliations

Soon will be listed here.

Abstract

Nicotine, the main compound in cigarettes, leads to smoking addiction. Nicotine acts on the limbic dopamine reward loop in the midbrain by binding to nicotinic acetylcholine receptors, promoting the release of dopamine, and resulting in a rewarding effect or satisfaction. This satisfaction is essential for continued and compulsive tobacco use, and therefore dopamine plays a crucial role in nicotine dependence. Numerous studies have identified genetic polymorphisms of dopaminergic pathways which may influence susceptibility to nicotine addiction. Dopamine levels are greatly influenced by synthesis, storage, release, degradation, and reuptake-related genes, including genes encoding tyrosine hydroxylase, dopamine decarboxylase, dopamine transporter, dopamine receptor, dopamine 3-hydroxylase, catechol--methyltransferase, and monoamine oxidase. In this paper, we review research progress on the effects of polymorphisms in the above genes on downstream smoking behavior and nicotine dependence, to offer a theoretical basis for the elucidation of the genetic mechanism underlying nicotine dependence and future personalized treatment for smoking cessation.

Citing Articles

Investigation of Depression and Post-Traumatic Growth in Renal Transplant Recipients via Self-Assessment.

Simsek Yaban Z, Bulbuloglu S J Pers Med. 2024; 14(9).

PMID: 39338253 PMC: 11433626. DOI: 10.3390/jpm14090999.

References

Huang W, Li M . Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry. 2009; 65(8):702-5. PMC: 2678413. DOI: 10.1016/j.biopsych.2008.11.024. View

Meloni R, Albanese V, Ravassard P, Treilhou F, Mallet J . A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum Mol Genet. 1998; 7(3):423-8. DOI: 10.1093/hmg/7.3.423. View

Muenstermann C, Clemens K . Epigenetic mechanisms of nicotine dependence. Neurosci Biobehav Rev. 2023; 156:105505. DOI: 10.1016/j.neubiorev.2023.105505. View

Ding Z, Li X, Chen H, Hou H, Hu Q . Harmane Potentiates Nicotine Reinforcement Through MAO-A Inhibition at the Dose Related to Cigarette Smoking. Front Mol Neurosci. 2022; 15:925272. PMC: 9271706. DOI: 10.3389/fnmol.2022.925272. View

Faraone S, Perlis R, Doyle A, Smoller J, Goralnick J, Holmgren M . Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57(11):1313-23. DOI: 10.1016/j.biopsych.2004.11.024. View

Li M, Cheng R, Ma J, Swan G . A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction. 2002; 98(1):23-31. DOI: 10.1046/j.1360-0443.2003.00295.x. View

Zhu F, Yan C, Wang Q, Zhu Y, Zhao Y, Huang J . An association study between dopamine D1 receptor gene polymorphisms and the risk of schizophrenia. Brain Res. 2011; 1420:106-13. DOI: 10.1016/j.brainres.2011.08.069. View

Dani J, Harris R . Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci. 2005; 8(11):1465-70. DOI: 10.1038/nn1580. View

OGara C, Stapleton J, Sutherland G, Guindalini C, Neale B, Breen G . Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment. Pharmacogenet Genomics. 2007; 17(1):61-7. DOI: 10.1097/01.fpc.0000236328.18928.4c. View

10.

Leventhal A, Lee W, Bergen A, Swan G, Tyndale R, Lerman C . Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. Drug Alcohol Depend. 2014; 138:109-17. PMC: 4095777. DOI: 10.1016/j.drugalcdep.2014.02.016. View

11.

Sabol S, Hu S, Hamer D . A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet. 1998; 103(3):273-9. DOI: 10.1007/s004390050816. View

12.

Mansvelder H, McGehee D . Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron. 2000; 27(2):349-57. DOI: 10.1016/s0896-6273(00)00042-8. View

13.

Mondoloni S, Nguyen C, Vicq E, Ciscato M, Jehl J, Durand-de Cuttoli R . Prolonged nicotine exposure reduces aversion to the drug in mice by altering nicotinic transmission in the interpeduncular nucleus. Elife. 2023; 12. PMC: 10259488. DOI: 10.7554/eLife.80767. View

14.

El-Boraie A, Chenoweth M, Pouget J, Benowitz N, Fukunaga K, Mushiroda T . Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations. Clin Pharmacol Ther. 2020; 110(4):975-985. PMC: 8187466. DOI: 10.1002/cpt.2135. View

15.

Perkins K, Lerman C, Coddington S, Jetton C, Karelitz J, Wilson A . Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. Behav Pharmacol. 2008; 19(5-6):630-40. PMC: 2743299. DOI: 10.1097/FBP.0b013e32830c3621. View

16.

Amara S, Sonders M . Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend. 1998; 51(1-2):87-96. DOI: 10.1016/s0376-8716(98)00068-4. View

17.

Liu C, Tose A, Verharen J, Zhu Y, Tang L, de Jong J . An inhibitory brainstem input to dopamine neurons encodes nicotine aversion. Neuron. 2022; 110(18):3018-3035.e7. PMC: 9509462. DOI: 10.1016/j.neuron.2022.07.003. View

18.

Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang B . Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet. 2006; 15(24):3498-507. DOI: 10.1093/hmg/ddl426. View

19.

Ling D, Niu T, Feng Y, Xing H, Xu X . Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence. J Hum Genet. 2003; 49(1):35-39. DOI: 10.1007/s10038-003-0104-5. View

20.

Mooney M, Sofuoglu M . Bupropion for the treatment of nicotine withdrawal and craving. Expert Rev Neurother. 2006; 6(7):965-81. DOI: 10.1586/14737175.6.7.965. View